Political, economic, or social advocacy are vehicles for altering existing structural systems, changing behavior on a large scale, and promoting a new status quo. High-capacity philanthropists are uniquely positioned to leverage their resources in the interests of generating social impact and systemic change.
Whether or not you decide to engage in advocacy should come down to your personal goals as a philanthropist. A few basic questions will guide you.
Do the changes I want to see in the world rely on more than philanthropy?
If you aim to address systemic problems that require public engagement or regulatory changes, then advocacy might be an appropriate vehicle to achieve your charitable priorities. Similarly, if you are passionate about amplifying the voices of vulnerable groups in society, advocacy is an excellent way to advance your cause.
How can I engage in advocacy?
Advocacy is often considered synonymous with lobbying, but its definition is much broader.It is any action that promotes a point of view or aims to influence others. The full spectrum of advocacy includes a wide variety of activities, including:
Grassroots mobilization
Public education campaigns
Publicity campaigning
Coalition building
Conducting research
Political lobbying
What do I need to be aware of before I start?
Your chosen philanthropic vehicle will determine the extent of your advocacy activities. For example, an LLC has more flexibility than a private foundation. Acting as an individual or via an LLC allows you to engage in direct lobbying or to make personal gifts to 501(c)(3) charitable nonprofits or 501(c)(4) social welfare organizations to promote a chosen cause. It’s important to remember that some of these tactics will not be tax deductible, including any contributions to an LLC or 501(c)(4) social welfare organization. Nonetheless, these groups have the potential to influence your objectives for social or environmental progress. We recommend consulting with your legal counsel to ensure compliance when engaging in advocacy activities.
The key lessons that policymakers must learn from the pandemic This article is the ninth in a weekly joint series on “The COVID-19 Pandemic and the Future of Aging” from the Milken Institute Center for the Future of Aging and Next Avenue...
What this thought leader thinks could improve the US response to the pandemic In this interview series from the Milken Institute Center for the Future of Aging and PBS' Next Avenue, experts from the Center's Advisory Board share their...
Future of Aging Advisory Board Academic and Policy Council Member
A world-renowned geriatrician and epidemiologist, Linda Fried has defined frailty and its causes, conducted research on the prevention of disability and cardiovascular disease, and proposes that investments in health for longer lives could build a Third Demographic Dividend.
Why this expert thinks a person-centered approach will be critical In this interview series from the Milken Institute Center for the Future of Aging and PBS' Next Avenue, experts from the Center's Advisory Board share their perspectives on...
Future of Aging Advisory Board Leadership Council Member
Robert Kramer is Founder and Strategic Advisor at the National Investment Center for Seniors Housing & Care (NIC), a non-profit education and resource center that serves debt and equity investors interested in the seniors housing and care industry.
Overview As Big Tech companies face continued scrutiny over their handling of personal health information, the limitations of US health privacy regulation in a digital age are becoming more evident. Policymakers, both in the US and around...
Insights from the former secretary of Housing and Urban Development This article is the eleventh in a weekly joint series on “The COVID-19 Pandemic and the Future of Aging” from the Milken Institute Center for the Future of Aging and Next...
Nobel Laureate Elizabeth Blackburn on how the pandemic may, and must, change things. This article is the twentieth in a weekly joint series on “The COVID-19 Pandemic and the Future of Aging” from the Milken Institute Center for the Future...
Future of Aging Advisory Board Academic and Policy Council Member
Throughout her long career in science, Dr. Blackburn has been a leader in the area of telomere and telomerase research, having discovered the molecular nature of telomeres – the ends of eukaryotic chromosomes that serve as protective caps essential for preserving the genetic information – and co-discovered the ribonucleoprotein enzyme, telomerase. She is also known for her championing of diversity and inclusion in the sciences.
In This Newsletter Tech in Rwanda AI at the Asia Summit Election Event Contracts The Emerging Tech Ecosystem in Rwanda In a conversation with Milken Institute CEO Rich Ditizio at the 2024 Milken Institute Asia Summit, President Paul Kagame...
Maxwell DeGregorio is an associate at MI Finance at the Milken Institute. DeGregorio works on the Institute’s FinTech Program, which focuses on access to capital, financial inclusion, compliance, and transparency. He writes the “FinTech in Focus” newsletter and co-programs the Institute’s FinTech content.
The pandemic’s impacts on disease prevention, science, and innovation In this interview series from the Milken Institute Center for the Future of Aging and PBS' Next Avenue, experts from the Center's Advisory Board share their perspectives...
Kevin Crain discusses solutions to the four retirement challenges employees face This article is the sixteenth in a weekly joint series on “The COVID-19 Pandemic and the Future of Aging” from the Milken Institute Center for the Future of...